Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
Zumedha - Investments

Research · Analysis · Insights

Zumedha - Investments

Research · Analysis · Insights

  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Stocks
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
  • Master Class
  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Stocks
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
  • Master Class
Close

Search

Zumedha - Investments

Research · Analysis · Insights

Zumedha - Investments

Research · Analysis · Insights

  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Stocks
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
  • Master Class
  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Stocks
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
  • Master Class
Close

Search

Home/IT Services/Persistent Systems Value Analysis April 2026
IT Services

Persistent Systems Value Analysis April 2026

April 7, 2026 8 Min Read
Updated on April 6, 2026
Persistent Systems — Equity Research Report
Zumedha Equity Research  ·  Deep Value Analysis
NSE: PERSISTENT  |  BSE: 533179
6 April 2026
Persistent Systems
Persistent Systems Limited  |  IT Services & Digital Engineering  |  Mid Cap
ACCUMULATE CMP: ₹5,317 (as on 6 Apr 2026)
52W High
₹6,599
52W Low
₹4,149
Market Cap
₹83,320 Cr
P/E (TTM)
48.6x
EPS FY25
₹91.22
Target Price
₹6,500
01 Business Overview

Persistent Systems Limited, incorporated in 1990 and headquartered in Pune, Maharashtra, is a mid-cap IT services and digital engineering company serving clients across Banking, Financial Services & Insurance (BFSI), Healthcare & Life Sciences (HLS), and Technology & Emerging Verticals. The company provides end-to-end software product engineering, cloud transformation, AI/ML, and enterprise modernisation services to over 700 clients across 19 countries.

Persistent’s strategic positioning rests on its vision “Re(AI)magining the World” — an AI-first approach to digital engineering underpinned by its proprietary GenAI platform SASVA and hyper-scaler partnerships with Microsoft, AWS, Google Cloud, and Salesforce. The company targets high-value sub-verticals such as intelligent insurance operations, personalised member experiences in healthcare, and AI-driven financial services.

With FY25 revenue crossing the milestone $1.4 billion mark and a brand valuation of $2.9 billion (Kantar BrandZ 2025, ranked 6th in Business Technology in India), Persistent has evolved from a niche product engineering company into a full-spectrum digital transformation partner. Its employee base of 24,500+ professionals, combined with 23 consecutive quarters of sequential revenue growth, speaks to a rare execution discipline in the mid-tier IT segment.

Revenue FY25
₹11,939 Cr
$1.409B | +18.8% YoY
EBIT Margin FY25
14.7%
Expanding on AI-led efficiency
PAT FY25
₹1,400 Cr
+28% YoY | 5yr CAGR 32.8%
ROCE / ROE
30.4% / 24.1%
Debt-free balance sheet
Promoter Holding
30.3%
Stable; no pledging
Book Value/Share
₹453
P/B: 11.7x
Dividend Yield
0.64%
₹22/sh interim FY26; payout 39%
Employees
24,500+
19 countries
02 Historical Financials

Persistent has delivered a remarkable financial trajectory since FY20, with revenue growing at a 5-year CAGR of ~27% and PAT at ~33%. Margins dipped during the global IT sector cost-push cycle of FY22–23 but have structurally recovered. All figures consolidated, in ₹ Crores.

Metric FY21 FY22 FY23 FY24 FY25 TTM
Revenue (₹ Cr) 4,188 5,711 8,351 9,822 11,939 13,935
Revenue Growth (%) 17.4% 36.4% 36.3% 17.6% 21.6% ~20%
Operating Profit (₹ Cr) 683 958 1,519 1,676 2,058 2,612
OPM (%) 16% 17% 18% 17% 17% 19%
PAT (₹ Cr) ~480 ~680 ~900 ~1,095 ~1,400 1,732
EPS (₹) ~33 ~44 ~58 ~71 91.22 ~110
PAT CAGR (5yr) 32.8% | Revenue CAGR: ~27%

Q3 FY26 snapshot: Revenue ₹3,778 Cr (+23.4% YoY); PAT ₹439 Cr (+17.8% YoY); OPM 19.4% (ex-one-time new labour code charge of ₹89 Cr). 23rd consecutive quarter of sequential revenue growth. Q3 FY26 order TCV: $674.5M; ACV: $501.9M.

03 DCF Valuation (10-Year Model)

We construct a 10-year discounted cash flow model using a WACC of 12% and terminal growth rate of 5%, consistent with Persistent’s medium-term USD revenue trajectory. FCF is proxied as PAT × 85% (adjusting for D&A and capex), conservatively reflecting tuck-in acquisitions. Base case assumes gradual revenue growth deceleration from ~18% to ~12% over the forecast horizon as the company scales past $2B USD revenue.

DCF
10-Year Free Cash Flow Model — Base Case
WACC
12.0%
Terminal Growth
5.0%
Shares Outstanding
~1.57 Cr
Base FCF (FY25E)
₹1,190 Cr
Intrinsic Value/Share
₹6,200
Upside vs CMP
+16.6%
Year FY26E FY27E FY28E FY29E FY30E FY31-35E Terminal
Revenue Gr% 20% 18% 16% 14% 13% 12–10% 5%
FCF (₹ Cr) 1,440 1,760 2,100 2,460 2,860 3,200–6,200 TV: ~₹82,000 Cr
PV of FCF 1,286 1,403 1,495 1,562 1,622 ~10,800 ~46,500 Cr
Total Enterprise Value (Base): ~₹64,668 Cr | Net Cash adjustment: ~₹3,000 Cr | Equity Value: ~₹97,500 Cr | Intrinsic Value/Share: ~₹6,200 | WACC sensitivity: at 11% → ₹7,100/sh; at 13% → ₹5,450/sh
04 Buy Range (3-Zone Framework)
▲ Buy Zones
Strong Buy — Deep Value Zone
₹4,100 – ₹4,600
Accumulate — Fair Entry Zone
₹4,600 – ₹5,400
Fair Value — Neutral Hold Zone
₹5,400 – ₹6,200

Current CMP of ₹5,317 sits in the Accumulate zone — attractive on dips below ₹5,200, especially ahead of Q4 FY26 results on 23 Apr 2026.

▼ Sell / Reduce Zones
Reduce — Premium Territory
₹6,600 – ₹7,200
Exit — Overvaluation Zone
₹7,200 – ₹8,000
Avoid — Speculative Excess
Above ₹8,000

Exit triggers: P/E above 65x, revenue growth decelerating below 10%, or significant management/promoter exits.

05 Buy Scenario Analysis — Bull / Base / Bear
Bear Case
₹3,800
US macro slowdown, tech spending cut; revenue growth decelerates to 8–10%; P/E compresses to 30x. AI hype fades for mid-tier IT.
Base Case
₹6,200
18–20% revenue growth sustained; EBIT margin expands to 16–17%; P/E stable at 45–50x. DCF-derived intrinsic value. 12M target.
Bull Case
₹8,500
AI-driven deal acceleration; revenue crosses $2.5B by FY28; margin expansion to 18–20%; re-rating to 60–65x P/E on quality premium.

Base case probability: 55% | Bull: 25% | Bear: 20%. Probability-weighted target: ~₹6,070 (upside ~14% from CMP). Catalyst for upside re-rating: AI-led deal wins exceeding $500M+ TCV per quarter; margin recovery to 16%+.

06 Sell Range

We define tactical and structural sell signals for Persistent Systems based on valuation stretch and earnings quality:

Reduce
₹6,600+
Stock approaching ATH; P/E above 58x with no earnings acceleration. Trim 20–30% of position.
Exit Trigger
₹7,200+
P/E above 65x and revenue growth slowing. Exit 50–75% on any negative surprise.
Structural Break
Below ₹4,100
Closes below 52W low on volume; revenue growth breakdown. Revisit investment thesis.
07 Sell Scenario Analysis
Overvalued
P/E > 60x
Stock re-rating exceeds earnings delivery. Begin systematic profit booking. Watch: TTM EPS vs price appreciation rate.
Exit Trigger
Rev < 12% YoY
Revenue growth normalisation without margin expansion destroys the growth premium. Revert to 30–35x sector P/E.
Structural Break
CEO exit / key loss
Key man risk: CEO Sandeep Kalra architects growth strategy. Any major leadership change warrants immediate thesis review.
08 Future Growth & Earnings Outlook
Revenue Roadmap
FY26E revenue of ~₹14,500–15,000 Cr (~$1.7B) is achievable given Q3 FY26 annualised run-rate of $1.7B. FY27E target of $2.0B+ requires sustained deal momentum at $600M+ TCV per quarter. Revenue CAGR of 18–20% expected through FY28.
Margin Expansion Thesis
EBIT margin of 14.7% in FY25 (adjusting for the new labour code one-time charge of ₹89 Cr in Q3 FY26). Agentic AI adoption within own operations targets 200–300 bps margin improvement by FY28. Pyramid optimisation and offshore shift support this trajectory.
AI & Deal Pipeline
Q3 FY26 TCV of $674.5M and ACV of $501.9M are the highest in company history. AI-driven deal velocity is accelerating across BFSI and HLS verticals. SASVA platform and NVIDIA partnership (GenMolVS for drug discovery) position Persistent at the forefront of agentic AI adoption.
EPS Forecast
FY26E EPS: ~₹115–120 | FY27E EPS: ~₹140–150. Assumes 20% PAT growth in FY26E and 22% in FY27E. Share buyback of 250,000 additional equity shares in Q4 FY26 provides marginal EPS accretion. Dividend payout of ~39% expected to continue.
Estimates FY26E FY27E FY28E
Revenue (₹ Cr)14,80017,40020,200
Revenue Growth (%)24%18%16%
EBIT Margin (%)15.5%16.5%17.5%
PAT (₹ Cr)1,7202,1002,580
EPS (₹)~118~145~178
P/E at CMP ₹5,31745.1x36.7x29.9x
09 Risks & Catalysts
Key Risks (Bear)
US macroeconomic slowdown reducing IT discretionary spend (79.6% revenue from North America)
Currency risk: INR appreciation vs USD compresses USD-revenue translation
Key-man risk: CEO Sandeep Kalra central to growth strategy and client relationships
Valuation premium (48x P/E) leaves limited margin of safety; earnings miss would cause sharp de-rating
AI commoditisation risk: GenAI tools reducing billable hours in software engineering services
Client concentration in BFSI and HLS verticals; sector-specific slowdown risk
Key Catalysts (Bull)
Q4 FY26 earnings beat on 23 Apr 2026 — consensus expecting ~20% revenue growth
Large deal wins ($100M+ TCV single deals) in AI engineering, which would signal client stickiness
EBIT margin recovery to 16%+ driven by Agentic AI internal deployment (“customer zero”)
Nifty 50 inclusion — eligibility improving as market cap approaches ₹1 lakh Cr
Strategic acquisitions expanding capabilities in high-value verticals (defence tech, climate tech)
India Revenue diversification — reducing dependence on US reduces macro vulnerability
10 Peer Comparison

Persistent commands a meaningful valuation premium over mid-tier IT peers, justified by its industry-leading revenue growth rate (~20%+ vs sector average of 5–10%). However, the premium narrows significantly on a forward P/E basis as earnings grow into the multiple.

Company CMP (₹) Mkt Cap (₹ Cr) Rev Gr (YoY) OPM% P/E (TTM) P/E (FY26E) ROCE% ROE%
Persistent Systems 5,317 83,320 23.4% 19% 48.6x 45.1x 30.4% 24.1%
Coforge ~7,100 ~48,000 ~20% ~15% ~38x ~32x ~28% ~22%
LTIMindtree ~4,800 ~1,42,000 ~5% ~17% ~30x ~28x ~34% ~28%
Mphasis ~2,700 ~51,000 ~6% ~15% ~28x ~25x ~26% ~22%
Hexaware ~750 ~45,000 ~14% ~14% ~35x ~30x ~25% ~20%
Infosys ~1,580 ~6,60,000 ~5% ~21% ~22x ~21x ~38% ~32%
HCL Technologies ~1,550 ~4,20,000 ~5% ~19% ~21x ~19x ~32% ~26%

Persistent’s P/E premium of ~55% over Infosys and HCL is anchored by its 4–5x higher revenue growth rate. If Persistent sustains 20%+ revenue growth and margins expand to 16%+, the FY27E P/E of ~37x compares favourably with Coforge at ~32x on lower growth. The key swing factor is whether AI-led deal wins can maintain velocity post FY26.


Investment Verdict
Accumulate — Premium Quality at a Discount to Peak
Persistent Systems is one of India’s finest mid-cap IT compounders — 23 consecutive quarters of revenue growth, debt-free balance sheet, 30%+ ROCE, and an AI-first strategy that is already translating into record deal wins. The stock has corrected ~19% from its ATH of ₹6,599, bringing the valuation to a more palatable 45–48x TTM P/E.

At ₹5,317, the CMP sits inside our Accumulate zone. The DCF-based intrinsic value of ₹6,200 offers ~16% upside in the base case, while the bull case of ₹8,500 captures the AI optionality premium. Investors with a 24–36 month horizon should accumulate on dips below ₹5,200, with a stop-loss at ₹4,100 (52W low support). The key near-term catalyst is Q4 FY26 results on 23 April 2026.
12-Month Target
₹6,500
+22.3% upside from CMP
Rating: ACCUMULATE
DCF Intrinsic: ₹6,200
Strong Buy below: ₹4,600
Stop-loss: ₹4,100
Risk/Reward: 1:2.2
Next event: Q4 FY26 results
23 April 2026
Disclaimer: This report is prepared for informational and educational purposes only and does not constitute investment advice, a solicitation, or an offer to buy or sell any securities. The analysis herein is based on publicly available information from NSE, BSE, Screener.in, Trendlyne, Tickertape, company filings, and analyst reports as of 6 April 2026. All financial projections are estimates and carry inherent uncertainty. Past performance is not indicative of future results. Investors should conduct their own due diligence and consult a SEBI-registered investment advisor before making investment decisions. The author/publisher is not responsible for any losses arising from the use of this report. This report does not constitute SEBI-registered research.
PERSISTENT  |  Deep Value Analysis  |  6 April 2026 CMP: ₹5,317  |  Target: ₹6,500  |  Rating: ACCUMULATE

Tags:

Mid Cap StocksPersistent Systems
Author

Zumedha Research Team

Follow Me
Other Articles
Previous

Infosys Ltd Share Value Analysis 2026

Next

Buy vs Accumulate Rating in Stocks: Key Differences Every Investor Must Know

Recent Posts

  • HDFC Bank (NSE: HDFCBANK) — Stock Analysis April 2026
  • Buy vs Accumulate Rating in Stocks: Key Differences Every Investor Must Know
  • Persistent Systems Value Analysis April 2026
  • Infosys Ltd Share Value Analysis 2026
  • InterGlobe Aviation (INDIGO) — Deep Dive Share Analysis
Legal Disclaimer Investment Research & Information

Not Investment Advice. All content published on this website — including stock analyses, mutual fund reviews, DCF models, valuation estimates, buying zones, and commentary — is created for our own educational, internal research and informational purposes only. Nothing on this website constitutes financial, investment, legal, or tax advice, nor a solicitation or recommendation to buy, sell, or hold any security or financial instrument.

No Guarantees. It is advised clearly and categorically not o follow these analysis and information blindly for your equity investement purpose as Equity investments and mutual funds are subject to market risks. Past performance is not indicative of future results. All DCF models, fair value estimates, and scenario analyses are based on publicly available data and the author's independent assumptions and may prove materially incorrect. The author/s or owners of this website/portal do not are not liable in whatsoever manner for any positive or negative outcome from your own investment endeavorsYou may lose part or all of your invested capital.

Do Your Own Research. Readers are strongly advised to consult a SEBI-registered investment advisor and conduct their own due diligence before making any investment decision. The author may or may not hold positions in securities discussed on this website.

No Obligations. We, the author/ the publisher/ anybody associated with Zumedha.com does not guarantee the accuracy, adequacy or completeness of any information/data and is not responsible for any errors or omissions or for the results obtained from the use of such information/data. Zumedha.com or anyone involved with zumedha.com will not accept any liability for loss or damage as a result of reliance on the Estimates data. It does not subscribe or endorse any of the services and/or content offered by such third party.

Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
This website is not registered as an Investment Adviser under SEBI (Investment Advisers) Regulations, 2013. All views are personal and for informational purposes only.
© 2026 · All Rights Reserved · For Educational Use Only. RESEARCH · ANALYSIS · INSIGHTS